Literature DB >> 31227314

Management of ureteropelvic junction obstruction in children-a roundtable discussion.

M Gopal1, M Peycelon2, A Caldamone3, R Chrzan4, A El-Ghoneimi5, H Olsen6, M-D Leclair7, A Stillebroer8, C MacDonald9, U Tonnhofer10, C Strasser11, A Adam12, A-F Spinoit13, B Haid11.   

Abstract

The investigation, management and follow-up of paediatric ureteropelvic junction obstruction is not standardized. The Young Pediatric Urology Committee of the European Society of Pediatric Urology interviewed five experts in the field on various aspects of management and compared this with published literature.
Copyright © 2019 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Children; Management; Ureteropelvic junction obstruction

Mesh：

Year:  2019        PMID： 31227314     DOI： 10.1016/j.jpurol.2019.05.010

Source DB:  PubMed          Journal:  J Pediatr Urol        ISSN： 1477-5131            Impact factor:   1.830


  4 in total

1.  DTI of the kidney in children: comparison between normal kidneys and those with ureteropelvic junction (UPJ) obstruction.

Authors:  Hansel J Otero; Juan S Calle-Toro; Carolina L Maya; Kassa Darge; Suraj D Serai
Journal:  MAGMA       Date:  2019-12-16       Impact factor: 2.310

2.  Potential benefits of functional magnetic resonance urography (fMRU) over MAG3 renal scan in children with obstructive uropathy.

Authors:  Bernarda Viteri; Juan S Calle-Toro; Lance Ballester; Kassa Darge; Susan Furth; Dmitry Khrichenko; Jason Van Batavia; Hansel Otero
Journal:  J Pediatr Urol       Date:  2021-07-10       Impact factor: 1.830

3.  Anterograde Mini-Percutaneous Retropelvic Extra-Luminal Endopyelotomy: A Novel Approach to Uretero-Pelvic Junction Obstruction.

Authors:  Amadadin Alhlib; Abdullah E Laher; Ahmed Adam
Journal:  Cureus       Date:  2022-02-25

4.  Learning curve or experience-related outcome: what really matters in paediatric laparoscopic pyeloplasty.

Authors:  Wojciech Panek; Jakub Szmer; Caroline F Kuijper; Rafal Chrzan
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2019-10-29       Impact factor: 1.195
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.